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Objective and Method: In this retrospective review, we report the surgical results of infected aortic aneurysms treated at a
single center over 5 years.
Results: From October 1996 to October 2001, 19 patients with infected aortic aneurysm were treated with surgery, nine
with suprarenal infections (four proximal descending thoracic aortic aneurysms, two distal descending thoracic aortic
aneurysms, and three suprarenal abdominal aortic aneurysms) and 10 with infrarenal infections (eight infrarenal
abdominal aortic aneurysms and two iliac artery aneurysms). All had a positive blood or tissue culture; 89% were febrile,
89% had leukocytosis, and 32% were hemodynamically unstable. The most common responsible pathogens were
Salmonella organisms (74%) followed by Streptococcus species (11%). Nine of 10 infrarenal infections were caused by
Salmonella organisms. Both infrarenal and suprarenal infections were treated with wide de´bridement of infected aorta, in
situ prosthetic graft or patch repair, and prolonged intravenous antibiotics. Hospital survival rate was 95%: 100% for
infrarenal and 89% for suprarenal infections. There was no perioperative intestinal ischemia or perioperative limb loss.
Acute renal failure occurred in two patients with suprarenal infection. Late deaths have occurred in three patients with
one early graft infection (5%) resulting in the only one in-hospital death at 4 months. Sixteen patients remain alive at mean
follow-up of 17.8 months (range, 4-47 months). There have been no late aortic or graft infections. During the same
period, there were five unoperated patients, four of whom died of shock during hospitalization.
Conclusions: Infected aortic aneurysm is common in Taiwan, and Salmonella species were the most common responsible
microorganisms. With surgical intervention and prolonged intravenous antibiotics, in situ graft replacement provided a
good outcome. The incidence of prosthetic graft infection was low, even in patients with infections due to Salmonella
species and with in situ graft replacement. (J Vasc Surg 2002;36:746-50.)
An infected aneurysm of the aorta and adjacent arteries
is a rare but life-threatening condition.1-4 The mortality
rate is extremely high in the absence of surgical treatment.
Surgical repair by either in situ graft replacement or extra-
anatomic reconstruction remains controversial. Previous
studies5-7 have reported that the prognosis is poor even
when surgery has been performed early in the disease
course. Traditionally, in situ graft replacement was contra-
indicated in patients with severe infection because the
chance of early graft infection was high in these patients,
whereas for extra-anatomic bypass, inferior patency and the
necessity of a future reconstruction are problems. Accord-
ing to our recent experience, disease of the infected aorta is
common in Taiwan and represents nearly 3% of all aortic
surgical procedures. Herein we report our surgical results
of infected aortic aneurysms treated in a single center over
5 years.
PATIENTS AND METHODS
Patient group. From October 1996 to October
2001, 24 patients were admitted to our hospital because of
primary infected aortic aneurysm. Surgery was performed
in 19 patients with infected aneurysms of the descending
thoracic aorta, abdominal aorta, and iliac arteries. Among
them, there were 13 men and 6 women with a mean age
standard deviation of 66.1 9.9 years (range, 51-85 years)
at the time of surgical intervention. The medical co-mor-
bidities included hypertension in seven; diabetes mellitus in
three; old stroke in three; idiopathic thrombocytopenic
purpura in two; and pure red cell anemia, liver cirrhosis
with hepatocellular carcinoma, uremia under hemodialysis,
bronchial asthma, and chronic alcoholism each in one
patient. During the same period, five patients with infected
aortic aneurysms had no surgery. In addition, surgery was
not performed in an 81-year-old man with an infected
infrarenal abdominal aortic aneurysm. He remained afe-
brile after 6 weeks of antibiotic treatment, and the repeated
computed tomographic scan 6 months after the initial
diagnosis of infected aneurysm showed a 3-cm aneurysm
and no evidence of rupture. Among the five unoperated
patients, four patients had aortic pseudoaneurysm measur-
ing 3- to 5 cm on imaging study and they refused operation
because of old age (all 80 years of age) and multiple
medical co-morbidities. All four patients died of shock
within 1 month after admission.
From the Department of Surgery and Institute of Clinical Medicine, Na-
tional Taiwan University Hospital, and Far Eastern Memorial Hospital.
Competition of interest: nil.
Reprint requests: Dr Shu-Hsun Chu, National Taiwan University Hospital,
No. 7, Chung-Shan S. Rd, Taipei, Taiwan 100, R.O.C. (e-mail:
shchu@ha.mc.ntu.edu.tw).
Published online Aug 8, 2002.
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00  0 24/1/126557
doi:10.1067/mva.2002.126557
746
Preoperative assessment and patient selection.
Clinically infectedaortic aneurysm was usually preceded by
infected aorta. Infected aorta was diagnosed on the basis of
clinical evidence of infection (fever and leukocytosis) and
periaortic soft-tissue infiltration demonstrated by imaging
study with use of either computed tomography8 or mag-
netic resonance imaging.9 Infected aortic aneurysm was
defined as aortic dilation with a diameter of3 cm. Among
our 19 surgical patients, four patients had infected aorta on
the initial imaging study and finally progressing to pseudo-
aneurysm formation on the repeated imaging study. Two
patients had infected aneurysm and 13 patients had in-
fected pseudoaneurysm on the initial study. Intravenous
antibiotic was given once the diagnosis of infected aorta was
confirmed. Patients with salmonella infection, were treated
with ceftriaxone, 1000-2000 g every 12 hours. For patients
with non-salmonella infection, antibiotic was used on the
basis of culture result and sensitivity testing. For patients
with good response to antibiotic treatment (no fever and
declining white blood cell count), surgical intervention was
considered after completed antibiotic treatment, 4 to 6
weeks. Early surgical intervention, which was defined as
operation before 4 to 6 weeks of antibiotic treatment, was
performed only in the situations of uncontrolled infection
(persistent fever or septic shock) or evidence of aortic
rupture (shock or large pseudoaneurysm formation on the
imaging study). No patient was operated on in the stage of
infected aorta.
Surgical treatment. Surgical management consisted
of wide de´bridement of necrotic tissue, copious saline
irrigation, and in situ repair with Dacron graft through a
thoracotomy, a thoracoabdominal incision, or a midline
laparotomy. For patients with proximal descending tho-
racic aneurysm immediately distal to the left subclavian
artery, cardiopulmonary bypass was instituted through the
femoral artery and femoral vein. Proximal aortic anastomo-
sis was performed under deep hypothermic circulatory ar-
rest. Once proximal anastomosis was completed, cardiopul-
monary bypass was re-instituted with cannulation of
prosthetic graft and simultaneous perfusion of both graft
cannula (upper body) and femoral artery (lower body).
Distal aortic anastomosis was done without hurry. For
patients with distal thoracic and abdominal aneurysms,
aortic anastomosis was performed with a simple clamp-and-
sew method. For patients with suprarenal abdominal aneu-
rysm involving visceral arteries, the visceral arteries were
re-implanted directly to the graft as an island pedicle.
The infected aorta was irrigated copiously with saline.
The abnormal aneurysm wall was not completely removed.
No bacteriologic analysis was used to determine an accept-
able resection margin.
Postoperative management. Antibiotics were admin-
istered intravenously in the hospital for at least 6 weeks after
the operation and until the clinical and laboratory parame-
ters (temperature, white blood cell count, and C-reactive
protein level) were normalized. Antibiotic continued orally
after discharge for at least 6 months, and some surgeons
prescribed life-long oral antibiotic. White blood cell count
and C-reactive protein level were monitored regularly to
assess the occurrence of reinfection. Some patients had
imaging studies with computed tomography or magnetic
resonance imaging after the operation.
Data collection. Data on age, sex, medical co-mor-
bidities, operation status, location of infected aorta, surgi-
cal procedure, and clinical outcome were collected retro-
spectively from medical records.
RESULTS
From October 1996 to October 2001, 19 patients with
mycotic aneurysms were treated with surgery, nine with
suprarenal infections (four proximal descending thoracic
aortic aneurysms, two distal descending thoracic aortic
aneurysms, and three suprarenal abdominal aortic aneu-
rysms) and 10 with infrarenal infections (eight infrarenal
abdominal aortic aneurysms and two iliac artery aneu-
rysms).
Patient data is shown in the table. During the opera-
tion, aortic pseudoaneurysm was present in 17 patients:
into the lungs in two patients, and into retroperitoneum or
periaortic tissue in 15 patients. Six patients underwent
emergency surgery because of aortic pseudoaneurysm (two
patients) and unstable hemodynamics (four patients).
Seven patients had early, but not emergency, surgical inter-
vention because of new appearance of large pseudoaneu-
rysm (3 cm) on imaging study. Aortic pseudoaneurysm
was found incidentally in four patients who underwent
elective surgery after complete antibiotic treatment.
All had positive blood or tissue cultures; 89% were
febrile, 89% had leukocytosis, and 79% had localized pain at
presentation. The mean duration  standard deviation of
preoperative antibiotic use was 14.5 11.2 days. Infection
was not adequately controlled, with persistent fever and
leukocytosis in seven patients before the operation. The
most common responsible organisms were Salmonella spe-
cies in 14 patients (74%) followed by Streptococcus species in
two patients (11%), and Staphylococcus aureus, Bacteroides
species and Mycobacterium tuberculosis, each in one patient.
In 10 patients with infrarenal infections, Salmonella species
were the most common microorganisms (90%). Frank pu-
rulent infection was observed in four patients: three pa-
tients had emergency surgery and no preoperative antibi-
otic treatment, and one patient had periaortic pus
accumulation in spite of 6 weeks of intravenous antibiotic
treatment. There were two salmonella, one staphylococcal,
and one streptococcal infection. The abnormal aorta was
not completely resected, and the remaining aortic wall was
copiously irrigated with warm saline.
Both infrarenal and suprarenal infections were treated
with wide de´bridement of infected aorta, in situ prosthetic
graft or patch repair, and prolonged postoperative intrave-
nous antibiotics. One patient with suprarenal abdominal
aneurysm had patch repair to shorten the visceral ischemic
time. We did not perform extra-anatomic reconstruction
with axillofemoral bypass in patients with infrarenal infec-
tions.
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Hospital outcome. In-hospital mortality rate was 5%:
0/10 (0%) for infrarenal infections and 1/9 (11%) for
suprarenal infections. Hospital death occurred in a 78-year-
old patient who had emergency surgery because of septic
shock and localized rupture of a suprarenal mycotic aneu-
rysm caused by Bacteroides species. He had early poly-
mocrobial prosthetic graft infection due to Bacteroides the-
taiotaomicron, Pseudomonas aeruginosa, and finally
Methicillin-resistant Staphylococcus aureus. He died of
overwhelming sepsis 4 months after the operation.
There was no perioperative intestinal ischemia or peri-
operative limb loss. Acute renal failure occurred in two
patients with suprarenal infection. Late deaths have oc-
curred in three patients: one early graft infection (5%)
resulting in the only in-hospital death at 4 months, one
patient died of upper gastrointestinal bleeding 4 months
after the operation, and one patient died of asthma and
respiratory failure 3 months after the operation. Sixteen
patients remain alive after a mean follow-up 23.6 months
(range, 4-63 months). There have been no late aortic or
graft infections.
Infected aortic aneurysm secondary to tuberculous in-
fection of the aorta is a rare entity.10,11 We added a new
case of an 85-year-old woman with proximal descending
thoracic aortic pseudoaneurysm. She presented with fever
and hemoptysis and underwent emergency surgery with in
situ graft replacement through the left thoracotomy with
use of partial cardiopulmonary support. Chest film and
computed tomography showed miliary tuberculosis. Cul-
ture of sputum yielded Mycobacterium tuberculosis. The
postoperative course was smooth, and she will receive an-
timicrobials as therapy for tuberculosis for 12 months.
DISCUSSION
Despite the recent improvements in surgical techniques
and antibiotic therapy, severe aortic infection and subse-
quent infected aortic aneurysms is still a highly lethal dis-
ease. Early diagnosis and a combination of surgical inter-
vention and prolonged antibiotic therapy are essential for
survival.1-4 The anatomic location of the aortic infec-
tion4,12 and the severity of infection13 are the main factors
determining the surgical outcome. The reported in-hospi-
tal mortality rates range from 16% to 44%.1-7 In our series,
the in-hospital mortality rate was 4/5 (80%) in unoperated
patients with aortic infection and 4/4 (100%) in patients
with aortic rupture.
The content of the aneurysmal sac is considered septic,
as proved by the high incidence of positive tissue cultures
during operation.1 Because of concern about graft infec-
tion, early studies4-7 suggested that extra-anatomic bypass
grafting was the method of choice for patients with infected
aneurysm of the infrarenal abdominal aorta. In situ graft
replacement was considered contraindicated, especially in
patients with infection due to S aureus, grossly purulent
infection, and infection due to Salmonella species because
the chance of early graft infection was high in these pa-
tients. However, in situ graft replacement was the preferred
procedure in patients with suprarenal lesions.14 Early graft
thrombosis in extra-anatomic reconstruction5 and pros-
thetic graft infection in graft replacement in situ were the
two major threats in the postoperative period. Recently,
more and more studies1-3 have shown that in situ repair
with synthetic material was successful if prompt confirma-
tion of infection was obtained, all possibly infected tissue
Table I. Patient data
Case no. Age (y) Sex Fever Pain Shock
Pseudoaneurysm
at operation Operation Hospital outcome Late death Pathogen
1 78 M      Dead  Bacteroides
2 51 M      Alive  Salmonella
3 74 M      Alive  Salmonella
4 58 M      Alive  Salmonella
5 62 M     Alive  Salmonella
6 61 F     Alive  Salmonella
7 54 M     Alive  Staphylococcus
8 72 M      Alive  Salmonella
9 76 F     Alive  Salmonella
10 71 M     Alive  Salmonella
11 61 F     Alive  Streptococcus
12 69 F     Alive  Salmonella
13 57 M     Alive  Salmonella
14 84 F     Alive  Tuberculosis
15 61 M     Alive  Salmonella
16 61 M     Alive  Salmonella
17 59 M     Alive  Salmonella
18 62 M     Alive  Salmonella
19 85 F      Alive  Streptococcus
20 82 F      Dead E. coli
21 80 M     – Dead Salmonella
22 83 M      Dead Salmonella
23 86 M      Dead Salmonella
24 81 M      Alive E. coli
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was resected, and antibiotic therapy was administered on
the basis of the sensitivity data for a prolonged period. The
primary determinants of clinical outcome in patients with
infected aortic aneurysm were not the operative approach,
but the virulence of the infecting organisms and the severity
of infection.13 To avoid late graft thrombosis and a second
operation, which were commonly seen in patients with
axillofemoral bypass, we performed in situ graft replace-
ment in all cases of suprarenal or infrarenal mycotic aneu-
rysms. To our surprise, the in-hospital mortality rate in our
study was 5%. Early prosthetic graft infection occurred in
one of all 19 patients and there was no late graft or aortic
infection clinically with a mean follow-up of 23.6 months.
We assumed that our low operative mortality rate and low
incidence of prosthetic graft infection were attributed to
prolonged intravenous antibiotic treatment, lack of severe
aortic infection, and possibly low virulence of infected
microorganisms. Because of high mortality rate in our
unoperated patients with infected aortic pseudoaneurysm,
we suggested early surgical intervention if there was evi-
dence of pseudoaneurysm on imaging study and prolonged
intravenous antibiotic treatment until biochemical param-
eters of inflammation (white blood cell count and C-reac-
tive protein level) return to normal. In our patients, fol-
low-up did not routinely include computed tomography or
magnetic resonance imaging. Seven of our 16 living pa-
tients had imaging studies 6 to 12 months after the opera-
tion, and there was no evidence of recurrent infection.
In Western countries, infected aortic aneurysms are
infrequently encountered, even in tertiary referral hospitals.
Most reports describe less than a dozen patients. One of the
largest series reported by Muller et al1 in 2001, included 33
patients over a 17-year period. We had 24 patients (19
operated and 5 unoperated cases) of primary infected an-
eurysm of descending thoracic aorta, abdominal aorta, and
iliac arteries over a 5-year period.
Infected aortic aneurysm is common in Taiwan. The
most common responsible organism of infected aorta in
previous studies was S aureus and Streptococcus species
followed by Salmonella organisms.1-7 In our study, Salmo-
nella species accounted for 74% of infections. Infections
due to Salmonella species are common, and their incidence
appears to be increasing in many countries.15 Non-typhoid
salmonella are widespread in nature and are commonly
associated with certain animals and food products.16 Sal-
monellosis may manifest in different clinical forms, and
endovascular infections are the most serious.17
There remain substantial questions regarding the opti-
mal therapeutic strategy. Previous studies reported that
in-hospital survival was poor in patients with aortic infec-
tion due to salmonella.7,18-20 In addition to aneurysm
rupture, salmonellosis was found to greatly increase the risk
of postoperative graft infection following in situ graft re-
placement.19 It was advisable to have an extra-anatomic
reconstruction in patients with infrarenal infection due to
salmonella. To the contrary, salmonella-infected aortic an-
eurysm is common in Taiwan.20-21 The surgical outcome
was good in our patients with such infections. In our 14
patients with salmonella infection, there were five patients
with suprarenal infections and nine patients with infrarenal
infections. There were no in-hospital deaths and no clinical
early or late prosthetic graft infection in patients with
salmonella infection and in situ graft replacement. All of
our patients with salmonella infections were responsive to
antibiotic treatment with ceftriaxone. Our excellent result
of in situ graft replacement in the context of salmonella
infection may be attributed to early diagnosis, a high re-
sponse rate to third-generation cephalosporins, and early
surgical intervention.
In conclusion, infected aortic aneurysm was common
in Taiwan and Salmonella species were the most common
responsible microorganisms. With surgical intervention
and prolonged intravenous antibiotic, in situ graft replace-
ment provided a good outcome. The incidence of pros-
thetic graft infection was low, even in patients with salmo-
nella infection and in situ graft replacement.
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